|
|
|
|
|
by refurb
2493 days ago
|
|
Considering nobody can get these drugs unless a physician prescribes them, when are we going to see a wholesale round up of doctors? So far it’s been a few high profile cases, but obviously the problem runs deeper than that. And J&J is by no means a major opioid manufacturer. As the article states, their drugs were less than 1% of all prescription opioids. I think J&J got hit because they have deep pockets. |
|
The had the non-hospital fentanyl market cornered for a while. Their patches were only for chronic use by patients already tolerant to opioids.
Even if they had less than 1% of the market, they would have had a much larger proportion of the high-dose market, where mortality risk ramps up.